FORT LAUDERDALE, Fla. — In some cases of pediatric pars planitis, surgical intervention may be necessary, but possible complications must be considered, according to a speaker.
At the Retina World Congress, Lisa J. Faia, MD, discussed a case in which a 12-year-old patient with inflammation secondary to pars planitis initially showed improvement after treatment with difluprednate followed by dorzolamide, oral steroids and mycophenolate. After 1 year, however, symptoms returned despite treatment with immunosuppressants.
“The inflammation improved, but inferior contraction started to